India to United States: Etoposide Export Trade Route
India has recorded 49 verified shipments of Etoposide exported to United States, representing a combined trade value of $1.7M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $35.5K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 97% of total export value with 39 shipments worth $1.7M USD. On the buying side, EVERSANA LIFE SCIENCES SERVICES,LLC is the largest importer in United States with $965.4K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, KOIT BIOPHARMA PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Etoposide corridor is one of India's established pharmaceutical export routes, with 49 shipments documented worth a combined $1.7M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 97% of all export value, reflecting the consolidated nature of India's etoposide manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $35.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during January–March, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 17.1%, placing it at rank #13 among India's top etoposide export destinations globally.
On the import side, key buyers of Indian etoposide in United States include EVERSANA LIFE SCIENCES SERVICES,LLC, EVERSANA LIFE SCIENCES SERVICES LLC, AMERISOURCE HEALTH SERVICES and 8 others. EVERSANA LIFE SCIENCES SERVICES,LLC is the single largest importer with 24 shipments valued at $965.4K USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ1
- Primary modeMulti-modal
- Top portSAHAR AIR
Market Position
- Global rank#13
- Annual growth+17.1%
- Demand growth+16.6%
- Regulatory ease68/100
Top 10 Indian Etoposide Exporters to United States
Showing top 10 of 7 Indian suppliers exporting Etoposide to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $43.2K per shipment | 39 | $1.7M | 97.0% |
| 2 | INTAS PHARMACEUTICALS LTD Avg $24.6K per shipment | 2 | $49.1K | 2.8% |
| 3 | KOIT BIOPHARMA PRIVATE LIMITED Avg $1.5K per shipment | 1 | $1.5K | 0.1% |
| 4 | GENEX PHARMA Avg $249 per shipment | 2 | $499 | 0.0% |
| 5 | VEA IMPEX I PRIVATE LIMITED Avg $134 per shipment | 2 | $267 | 0.0% |
| 6 | VEA IMPEX (I) PRIVATE LIMITED Avg $75 per shipment | 2 | $149 | 0.0% |
| 7 | ATLAS ENTERPRISES Avg $120 per shipment | 1 | $120 | 0.0% |
This table shows the top 10 of 7 Indian companies exporting etoposide to United States, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, KOIT BIOPHARMA PRIVATE LIMITED, GENEX PHARMA, VEA IMPEX I PRIVATE LIMITED, VEA IMPEX (I) PRIVATE LIMITED, ATLAS ENTERPRISES. INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 39 shipments worth $1.7M USD, giving it a 97% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Etoposide Importers in United States
Showing top 10 of 11 known buyers in United States receiving Etoposide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian etoposide in United States include EVERSANA LIFE SCIENCES SERVICES,LLC, EVERSANA LIFE SCIENCES SERVICES LLC, AMERISOURCE HEALTH SERVICES, EVERSANA LIFE SCIENCES SERVICES,LL, EVERSANA LIFE SCIENCES SERVICESLLC, among 11 total buyers. The largest importer is EVERSANA LIFE SCIENCES SERVICES,LLC, accounting for $965.4K USD across 24 shipments — representing 56% of all etoposide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCES SERVICES,LLC | 24 | $965.4K | 55.5% |
| 2 | EVERSANA LIFE SCIENCES SERVICES LLC | 10 | $344.7K | 19.8% |
| 3 | AMERISOURCE HEALTH SERVICES | 4 | $302.5K | 17.4% |
| 4 | EVERSANA LIFE SCIENCES SERVICES,LL | 2 | $83.4K | 4.8% |
| 5 | EVERSANA LIFE SCIENCES SERVICESLLC | 1 | $39.8K | 2.3% |
| 6 | S LO SA DE CV | 1 | $1.5K | 0.1% |
| 7 | TO THE ORDER OF | 2 | $499 | 0.0% |
| 8 | To The Order of Invoice raised to | 1 | $220 | 0.0% |
| 9 | TO THE ORDER OF INVOICE RAISED TO | 2 | $149 | 0.0% |
| 10 | JULIO MAGALLON GARCIA | 1 | $120 | 0.0% |
Showing top 10 of 11 Etoposide importers in United States on this route.
Top 10 Etoposide Formulations Imported by United States
Showing top 10 of 31 product formulations shipped on the India to United States Etoposide route, ranked by trade value
United States imports a wide range of etoposide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA DRUGS & MEDI ETOPOSIDE INJ.USP 20MG/ML25ML(US-ACC AS PER INVOICE — accounts for $246.7K USD across 5 shipments. There are 31 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA DRUGS & MEDI ETOPOSIDE INJ.USP 20MG/ML25ML(US-ACC AS PER INVOICE | 5 | $246.7K | 14.2% |
| 2 | PHR DRUGS&MEDI ETOPOSIDE INJ.USP 20MG/ML | 5 | $216.2K | 12.4% |
| 3 | PHARMA DRUGS & MEDI ETOPOSIDE INJ.USP 20MG/ML50ML(US-ACC AS PER INVOICE | 4 | $166.5K | 9.6% |
| 4 | PHARMA DRUGS & MEDI ETOPOSIDE INJ.USP 20MG/ML25MLBLUEPOI-US AS PER DOCUMENT | 1 | $110.0K | 6.3% |
| 5 | PHARMA DRUGS & MEDI ETOPOSIDE INJ.USP 20MG/ML25ML(BLUEPOI-US AS PER INVOICE | 1 | $107.2K | 6.2% |
| 6 | PHA.DRU & MEDI, ETOPOSIDE INJ.USP 20MG/ML25ML(US-ACC Each mL contains: Etoposide 20mg Anhydrous citric acid 2 | 1 | $89.7K | 5.2% |
| 7 | PHA.DRU & MEDI, ETOPOSIDE INJ.USP 20MG/M | 2 | $88.8K | 5.1% |
| 8 | PHA.DRU & MEDI, ETOPOSIDE INJ.USP 20MG/ML25ML(US-ACC EACH ML CONTAINS : ETOPOSIDE #.. 20 MG ANHYDROUS CITRIC | 2 | $87.1K | 5.0% |
| 9 | PHA.DRU & MEDI, ETOPOSIDE INJ.USP 20MG/ML50ML(US-ACC EACH ML CONTAINS : ETOPOSIDE #.. 20 MG ANHYDROUS CITRIC | 1 | $60.6K | 3.5% |
| 10 | PHA.DRU & MEDI ETOPOSIDE INJ. USP 20MG/ML 5ML Each mL contains: Etoposide USP 20.00 mg Benzyl Alcohol USNF 30.00 mg Deh | 1 | $50.2K | 2.9% |
Showing top 10 of 31 Etoposide formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
SAHAR AIR handles the highest volume with 20 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's etoposide exports to United States are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 39 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, KOIT BIOPHARMA PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $35.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as phr drugs&medi etoposide inj.usp 20mg/ml and pharma drugs & medi etoposide inj.usp 20mg/ml50ml(us-acc as per invoice, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EVERSANA LIFE SCIENCES SERVICES,LLC is the largest importer with 24 shipments worth $965.4K USD — representing 56% of all etoposide imports from India on this route. A total of 11 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.7M
- Avg. Shipment
- $35.5K
- Suppliers
- 7
- Buyers
- 11
- Transit (Sea)
- ~25 days
- Annual Growth
- +17.1%
Reverse Direction
United States → India — Etoposide (Import)Other Etoposide Routes
Unlock the Full India to United States Etoposide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 49 shipments on this route.
Frequently Asked Questions — India to United States Etoposide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Etoposide to United States?
The leading Indian exporters of Etoposide to United States are INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, KOIT BIOPHARMA PRIVATE LIMITED. INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 97% of total trade value on this route.
Q What is the total value of Etoposide exports from India to United States?
India exports Etoposide to United States worth approximately $1.7M USD across 49 recorded shipments. The average value per shipment is $35.5K USD.
Q Which ports does India use to ship Etoposide to United States?
The most active port of origin is SAHAR AIR with 20 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 17% by air.
Q How long does shipping take from India to United States for Etoposide?
The average transit time for Etoposide shipments from India to United States is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Etoposide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 17.1% with demand growth tracking at 16.6%. The route is ranked #13 among India's top Etoposide export destinations globally.
Q How many suppliers are active on the India to United States Etoposide route?
There are currently 7 active Indian suppliers exporting Etoposide to United States. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 97% of total shipment value.
Q Who are the main importers of Etoposide from India in United States?
The leading importers of Indian Etoposide in United States include EVERSANA LIFE SCIENCES SERVICES,LLC, EVERSANA LIFE SCIENCES SERVICES LLC, AMERISOURCE HEALTH SERVICES, EVERSANA LIFE SCIENCES SERVICES,LL, EVERSANA LIFE SCIENCES SERVICESLLC. EVERSANA LIFE SCIENCES SERVICES,LLC is the largest buyer with 24 shipments worth $965.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Etoposide.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 11 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 49 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
49 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists